A targeted toxin based on a binding module of non-immunoglobulin scaffold as a new agent for theranostics

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The aim of the investigation was to create multifunctional antitumor protein agent DARPin-mCherry-PE40 possessing both diagnostic and therapeutic properties. Materials and Methods. The experiments were carried out on human cell lines of breast adenocarcinoma SK-BR-3. Chinese hamster ovarian cell line CHO-K1 was used as a control. Genetic engineering methods, metal chelate affinity chromatography, confocal microscopy and spectrophotometric MTT test were used to perform the experiments. Results. A multifunctional targeted anticancer protein agent DARPin-mCherry-PE40 consisting of targeted HER2-specific nonimmunoglobulin module DARPin, an imaging module mCherry and cytotoxic module based on a fragment of Pseudomonas exotoxin A (PE40) has been created. Using HER2-positive cells it was shown in vitro that all three domains of the recombinant protein retained their functional qualities — high affinity for HER2 antigen, ability to fluorescence, and cytotoxicity. Conclusion. The ability of the targeted antitumor agent DARPin-mCherry-PE40 selectively stains HER2-positive cells and highly selective cytotoxicity against these cells make this targeted recombinant protein DARPin-mCherry-PE40 a perspective theranostic agent for the diagnosis and treatment of HER2-positive human tumors.

Cite

CITATION STYLE

APA

Proshkina, G. M., Stremovskiy, O. A., Sibrikova, D. V., Ryabova, A. V., & Deyev, S. M. (2016). A targeted toxin based on a binding module of non-immunoglobulin scaffold as a new agent for theranostics. Sovremennye Tehnologii v Medicine, 8(4), 7–12. https://doi.org/10.17691/stm2016.8.4.01

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free